Nektar Therapeutics
(NKTR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-1999 | 03-1999 | 12-1998 | 09-1998 | 06-1998 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 0 | 0 | -18,350 | -12,040 | 0 |
| Depreciation Amortization | 0 | 0 | 3,590 | 2,440 | 0 |
| Other Working Capital | 0 | 0 | -4,740 | -7,250 | 0 |
| Other Operating Activity | -14,910 | -3,580 | 280 | 10 | -10,810 |
| Operating Cash Flow | $-14,910 | $-3,580 | $-19,220 | $-16,840 | $-10,810 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -9,920 | -5,740 | -34,580 | -21,540 | -16,150 |
| Net Acquisitions | 0 | 2,380 | 0 | 0 | 0 |
| Other Investing Activity | 14,240 | 0 | 28,080 | 40,610 | 39,340 |
| Investing Cash Flow | $4,320 | $-3,360 | $-6,500 | $19,070 | $23,190 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 340 | 50 | 36,530 | 1,120 | 1,150 |
| Financing Cash Flow | $340 | $50 | $36,530 | $1,120 | $1,150 |
| Beginning Cash Position | 24,910 | 24,910 | 14,100 | 14,940 | 14,940 |
| End Cash Position | 14,670 | 18,020 | 24,910 | 18,310 | 28,480 |
| Net Cash Flow | $-10,240 | $-6,890 | $10,810 | $3,360 | $13,530 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,910 | -3,580 | -19,220 | -16,840 | -10,810 |
| Free Cash Flow | -14,910 | -3,580 | -19,220 | -16,840 | -10,810 |